世界の感染性疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Communicable Diseases Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1490 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、感染性疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・感染性疾患治療の市場動向 ・企業の競争状況、市場シェア ・感染性疾患治療の種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV） ・感染性疾患治療の用途別市場規模（病院、クリニック、その他） ・感染性疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・感染性疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染性疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染性疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染性疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Gilead、GSK、Janssen Pharmaceutical、Roche、BioCryst Pharmaceuticals、Merck、Boehringer Ingelheim） ・結論

In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites

Market Analysis and Insights: Global Communicable Diseases Treatment Market
The global Communicable Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Communicable Diseases Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Communicable Diseases Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Communicable Diseases Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Communicable Diseases Treatment market.

Global Communicable Diseases Treatment Scope and Market Size
Communicable Diseases Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Communicable Diseases Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HIV
Influenza
TB
Malaria
Hepatitis
HPV

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Communicable Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HIV
1.2.3 Influenza
1.2.4 TB
1.2.5 Malaria
1.2.6 Hepatitis
1.2.7 HPV
1.3 Market by Application
1.3.1 Global Communicable Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Communicable Diseases Treatment Market Perspective (2016-2027)
2.2 Communicable Diseases Treatment Growth Trends by Regions
2.2.1 Communicable Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Communicable Diseases Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Communicable Diseases Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Communicable Diseases Treatment Industry Dynamic
2.3.1 Communicable Diseases Treatment Market Trends
2.3.2 Communicable Diseases Treatment Market Drivers
2.3.3 Communicable Diseases Treatment Market Challenges
2.3.4 Communicable Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Communicable Diseases Treatment Players by Revenue
3.1.1 Global Top Communicable Diseases Treatment Players by Revenue (2016-2021)
3.1.2 Global Communicable Diseases Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Communicable Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Communicable Diseases Treatment Revenue
3.4 Global Communicable Diseases Treatment Market Concentration Ratio
3.4.1 Global Communicable Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Communicable Diseases Treatment Revenue in 2020
3.5 Communicable Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Communicable Diseases Treatment Product Solution and Service
3.7 Date of Enter into Communicable Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Communicable Diseases Treatment Breakdown Data by Type
4.1 Global Communicable Diseases Treatment Historic Market Size by Type (2016-2021)
4.2 Global Communicable Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Communicable Diseases Treatment Breakdown Data by Application
5.1 Global Communicable Diseases Treatment Historic Market Size by Application (2016-2021)
5.2 Global Communicable Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Communicable Diseases Treatment Market Size (2016-2027)
6.2 North America Communicable Diseases Treatment Market Size by Type
6.2.1 North America Communicable Diseases Treatment Market Size by Type (2016-2021)
6.2.2 North America Communicable Diseases Treatment Market Size by Type (2022-2027)
6.2.3 North America Communicable Diseases Treatment Market Size by Type (2016-2027)
6.3 North America Communicable Diseases Treatment Market Size by Application
6.3.1 North America Communicable Diseases Treatment Market Size by Application (2016-2021)
6.3.2 North America Communicable Diseases Treatment Market Size by Application (2022-2027)
6.3.3 North America Communicable Diseases Treatment Market Size by Application (2016-2027)
6.4 North America Communicable Diseases Treatment Market Size by Country
6.4.1 North America Communicable Diseases Treatment Market Size by Country (2016-2021)
6.4.2 North America Communicable Diseases Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Communicable Diseases Treatment Market Size (2016-2027)
7.2 Europe Communicable Diseases Treatment Market Size by Type
7.2.1 Europe Communicable Diseases Treatment Market Size by Type (2016-2021)
7.2.2 Europe Communicable Diseases Treatment Market Size by Type (2022-2027)
7.2.3 Europe Communicable Diseases Treatment Market Size by Type (2016-2027)
7.3 Europe Communicable Diseases Treatment Market Size by Application
7.3.1 Europe Communicable Diseases Treatment Market Size by Application (2016-2021)
7.3.2 Europe Communicable Diseases Treatment Market Size by Application (2022-2027)
7.3.3 Europe Communicable Diseases Treatment Market Size by Application (2016-2027)
7.4 Europe Communicable Diseases Treatment Market Size by Country
7.4.1 Europe Communicable Diseases Treatment Market Size by Country (2016-2021)
7.4.2 Europe Communicable Diseases Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Communicable Diseases Treatment Market Size (2016-2027)
8.2 Asia-Pacific Communicable Diseases Treatment Market Size by Type
8.2.1 Asia-Pacific Communicable Diseases Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Communicable Diseases Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Communicable Diseases Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Communicable Diseases Treatment Market Size by Application
8.3.1 Asia-Pacific Communicable Diseases Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Communicable Diseases Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Communicable Diseases Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Communicable Diseases Treatment Market Size by Region
8.4.1 Asia-Pacific Communicable Diseases Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Communicable Diseases Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Communicable Diseases Treatment Market Size (2016-2027)
9.2 Latin America Communicable Diseases Treatment Market Size by Type
9.2.1 Latin America Communicable Diseases Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Communicable Diseases Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Communicable Diseases Treatment Market Size by Type (2016-2027)
9.3 Latin America Communicable Diseases Treatment Market Size by Application
9.3.1 Latin America Communicable Diseases Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Communicable Diseases Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Communicable Diseases Treatment Market Size by Application (2016-2027)
9.4 Latin America Communicable Diseases Treatment Market Size by Country
9.4.1 Latin America Communicable Diseases Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Communicable Diseases Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Communicable Diseases Treatment Market Size (2016-2027)
10.2 Middle East & Africa Communicable Diseases Treatment Market Size by Type
10.2.1 Middle East & Africa Communicable Diseases Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Communicable Diseases Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Communicable Diseases Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Communicable Diseases Treatment Market Size by Application
10.3.1 Middle East & Africa Communicable Diseases Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Communicable Diseases Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Communicable Diseases Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Communicable Diseases Treatment Market Size by Country
10.4.1 Middle East & Africa Communicable Diseases Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Communicable Diseases Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Communicable Diseases Treatment Introduction
11.1.4 Novartis Revenue in Communicable Diseases Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Gilead
11.2.1 Gilead Company Details
11.2.2 Gilead Business Overview
11.2.3 Gilead Communicable Diseases Treatment Introduction
11.2.4 Gilead Revenue in Communicable Diseases Treatment Business (2016-2021)
11.2.5 Gilead Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Communicable Diseases Treatment Introduction
11.3.4 GSK Revenue in Communicable Diseases Treatment Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Janssen Pharmaceutical
11.4.1 Janssen Pharmaceutical Company Details
11.4.2 Janssen Pharmaceutical Business Overview
11.4.3 Janssen Pharmaceutical Communicable Diseases Treatment Introduction
11.4.4 Janssen Pharmaceutical Revenue in Communicable Diseases Treatment Business (2016-2021)
11.4.5 Janssen Pharmaceutical Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Communicable Diseases Treatment Introduction
11.5.4 Roche Revenue in Communicable Diseases Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 BioCryst Pharmaceuticals
11.6.1 BioCryst Pharmaceuticals Company Details
11.6.2 BioCryst Pharmaceuticals Business Overview
11.6.3 BioCryst Pharmaceuticals Communicable Diseases Treatment Introduction
11.6.4 BioCryst Pharmaceuticals Revenue in Communicable Diseases Treatment Business (2016-2021)
11.6.5 BioCryst Pharmaceuticals Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Communicable Diseases Treatment Introduction
11.7.4 Merck Revenue in Communicable Diseases Treatment Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Communicable Diseases Treatment Introduction
11.8.4 Boehringer Ingelheim Revenue in Communicable Diseases Treatment Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Communicable Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HIV
Table 3. Key Players of Influenza
Table 4. Key Players of TB
Table 5. Key Players of Malaria
Table 6. Key Players of Hepatitis
Table 7. Key Players of HPV
Table 8. Global Communicable Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Communicable Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Communicable Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Communicable Diseases Treatment Market Share by Regions (2016-2021)
Table 12. Global Communicable Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Communicable Diseases Treatment Market Share by Regions (2022-2027)
Table 14. Communicable Diseases Treatment Market Trends
Table 15. Communicable Diseases Treatment Market Drivers
Table 16. Communicable Diseases Treatment Market Challenges
Table 17. Communicable Diseases Treatment Market Restraints
Table 18. Global Communicable Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Communicable Diseases Treatment Market Share by Players (2016-2021)
Table 20. Global Top Communicable Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Communicable Diseases Treatment as of 2020)
Table 21. Ranking of Global Top Communicable Diseases Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Communicable Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Communicable Diseases Treatment Product Solution and Service
Table 25. Date of Enter into Communicable Diseases Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Communicable Diseases Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Communicable Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Communicable Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Communicable Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Communicable Diseases Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Communicable Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Communicable Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Communicable Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Communicable Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Communicable Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Communicable Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Communicable Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Communicable Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Communicable Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Communicable Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Communicable Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Communicable Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Communicable Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Communicable Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Communicable Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Communicable Diseases Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Communicable Diseases Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Communicable Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Communicable Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Communicable Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Communicable Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Communicable Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Communicable Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Communicable Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Communicable Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Communicable Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Communicable Diseases Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Communicable Diseases Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Communicable Diseases Treatment Product
Table 68. Novartis Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Gilead Company Details
Table 71. Gilead Business Overview
Table 72. Gilead Communicable Diseases Treatment Product
Table 73. Gilead Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 74. Gilead Recent Development
Table 75. GSK Company Details
Table 76. GSK Business Overview
Table 77. GSK Communicable Diseases Treatment Product
Table 78. GSK Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 79. GSK Recent Development
Table 80. Janssen Pharmaceutical Company Details
Table 81. Janssen Pharmaceutical Business Overview
Table 82. Janssen Pharmaceutical Communicable Diseases Treatment Product
Table 83. Janssen Pharmaceutical Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 84. Janssen Pharmaceutical Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Communicable Diseases Treatment Product
Table 88. Roche Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. BioCryst Pharmaceuticals Company Details
Table 91. BioCryst Pharmaceuticals Business Overview
Table 92. BioCryst Pharmaceuticals Communicable Diseases Treatment Product
Table 93. BioCryst Pharmaceuticals Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 94. BioCryst Pharmaceuticals Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Communicable Diseases Treatment Product
Table 98. Merck Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Revenue in Communicable Diseases Treatment Business (2016-2021) & (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Communicable Diseases Treatment Market Share by Type: 2020 VS 2027
Figure 2. HIV Features
Figure 3. Influenza Features
Figure 4. TB Features
Figure 5. Malaria Features
Figure 6. Hepatitis Features
Figure 7. HPV Features
Figure 8. Global Communicable Diseases Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Other Case Studies
Figure 12. Communicable Diseases Treatment Report Years Considered
Figure 13. Global Communicable Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Communicable Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Communicable Diseases Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Communicable Diseases Treatment Market Share by Regions (2022-2027)
Figure 17. Global Communicable Diseases Treatment Market Share by Players in 2020
Figure 18. Global Top Communicable Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Communicable Diseases Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Communicable Diseases Treatment Revenue in 2020
Figure 20. Global Communicable Diseases Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Communicable Diseases Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Communicable Diseases Treatment Market Share by Type (2016-2027)
Figure 24. North America Communicable Diseases Treatment Market Share by Application (2016-2027)
Figure 25. North America Communicable Diseases Treatment Market Share by Country (2016-2027)
Figure 26. United States Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Communicable Diseases Treatment Market Share by Type (2016-2027)
Figure 30. Europe Communicable Diseases Treatment Market Share by Application (2016-2027)
Figure 31. Europe Communicable Diseases Treatment Market Share by Country (2016-2027)
Figure 32. Germany Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Communicable Diseases Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Communicable Diseases Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Communicable Diseases Treatment Market Share by Region (2016-2027)
Figure 42. China Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Communicable Diseases Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Communicable Diseases Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Communicable Diseases Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Communicable Diseases Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Communicable Diseases Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Communicable Diseases Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Communicable Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Novartis Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 62. Gilead Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 64. Janssen Pharmaceutical Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 66. BioCryst Pharmaceuticals Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 68. Boehringer Ingelheim Revenue Growth Rate in Communicable Diseases Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---